EGFR and lung cancer: By using a KrasG12D-induced spontaneous lung cancer mouse model and Zdhhc20 knockout mice, researchers demonstrated that the ablation of ZDHHC20 or induction of EGFRC1025A mutant inhibited tumorigenesis, which seems contradictory to the increased EGFR activation.